2026 Q1 Portfolio Activity
In 2026 Q1, Royalty Pharma Sub-Manager, LLC maintained a portfolio of 4 distinct positions.
Position History
hover any row below to update
Loading…
Total Positions
4
Quarter
2026 Q1
Top Holding
CYTK (36.4%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-4 of 4
Royalty Pharma Sub-Manager, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CYTK
CYTOKINETICS, I...
|
Healthcare | 36.36% | — |
#1
Prev: #—
|
9.5 |
—
|
980,392 | — |
NEW
|
980,392 | $62,294,108 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-01 | |||
|
BCAX
ZENAS BIOPHARMA...
|
Healthcare | 26.77% | — |
#2
Prev: #—
|
9.0 |
—
|
1,263,150 | — |
NEW
|
1,263,150 | $45,864,977 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-01 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 19.35% | — |
#3
Prev: #—
|
8.5 |
—
|
2,936,507 | — |
NEW
|
2,936,507 | $33,153,164 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-01 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 17.51% | — |
#4
Prev: #—
|
8.0 |
—
|
3,846,154 | — |
NEW
|
3,846,154 | $30,000,001 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-04-01 |
Showing 1-4 of 4 holdings